About Ryan Beattie
Ryan Beattie joined Beasley Allen in 2016 and focuses on talcum powder/ovarian cancer and hair relaxer/cancer litigation. He has played a key role in winning significant verdicts against Johnson and Johnson in talc lawsuits, including helping secure a $40 million verdict in California, and contributed to five landmark talc trials in which juries awarded significant damages. Ryan is a member of the Alabama State Bar, the Alabama State Bar Young Lawyers Section, and the American Association for Justice. He earned his B.S. in Business Administration and his J.D. from the University of Nebraska College of Law.
Proven verdicts and settlements at Beasley Allen
These results are credited to Beasley Allen. A result appears under an attorney's own name only when a published source names them as counsel on the case.
As chair of the plaintiffs' negotiating committee and Liaison Counsel in the Vioxx multidistrict litigation, Russ Herman directed the negotiations that produced a $4.85 billion settlement with Merck resolving approximately 45,000 to 50,000 personal-injury claims.
Monsanto and its chemical spinoff Solutia agreed in August 2003 to pay $700 million to resolve claims from more than 21,000 Anniston, Alabama residents who were exposed to polychlorinated biphenyls the company manufactured and dumped near their homes for nearly four decades.
San Francisco Unified School District's case was the first JUUL bellwether trial against Altria; after the plaintiffs rested, Altria agreed to pay $235 million to resolve roughly 6,000 pending e-vapor claims nationwide.
Beasley Allen, representing Alabama on contingency, secured $220 million from opioid distributors Cardinal Health and Cencora after roughly 18 months of litigation, with every dollar directed to statewide opioid abatement programs.
Prior results do not guarantee a similar outcome. Each case is unique and depends on its own facts.
Practice areas
Education
Bar admissions & credentials
Other attorneys at Beasley Allen
View firm →
